The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
SIG – EAHP guidance on the pharmacy handling of in vivo gene therapy medicinal products
Affiliation
Capital Region Pharmacy
Country
Denmark
Current position
Helle McNulty is currently Chief business development officer at The Capital Region Pharmay in Copenhagen. The role entails portfolio management, innovation and responsibility for a range of climate initiatives in relation to medicine and medicine usage.
Education
Helle McNulty holds a MSc. Pharm, DMS, (Diploma in Management studies, University of Leicester), DTU-UC Berkeley Executive Leadership Program, Innovation Leadership. Helle has contributed to numerous publications including a patent.
Research area
Helle McNulty has a background as a professional in hospital pharmacy management, clinical pharmacy, research, CIVA service management with focus on chemotherapy, GMP, clinical trials, and ATMP therapy.
A proven track record in product innovation with operational experience in all the development phases from IP to market access.
Conflict of interest
None